Smart Money Alert

Concord Biotech Limited

New PositionBulk Deal

CONCORDBIOPharmaceuticalsMarket Cap₹14K Cr

Deal value

₹180.86 Cr

Deal price

₹1,404.10

12.88 L

Trade date

31 Aug 2026

Since alert−8.8%₹1,484.30 → ₹1,353.30

Nifty 50−4.4%

DSP Mutual Fund

Mutual Fund

The move

DSP Mutual Fund bought 12,88,114 shares of Concord Biotech Limited for ₹180.86 Cr at ₹1404.10 apiece in a bulk deal.

About Concord Biotech Limited

Visit stock

An R&D-driven biopharma company engaged in manufacturing fermentation-based active pharmaceutical ingredients for immunosuppressants and oncology applications. Established in 1984, the company specializes in complex fermentation technology and serves domestic and international pharmaceutical markets with differentiated API solutions. Its focus on bioprocess innovation and vertical integration in fermentation-based manufacturing distinguishes it within the competitive global pharmaceutical ingredients landscape.

About DSP Mutual Fund

Visit investor

Standalone AMC after DSP Group acquired full ownership from BlackRock in 2018. Manages over Rs 1.9 lakh crore. Known for equity funds with a clear process-first culture and minimal star manager dependency. CEO Kalpen Parekh is widely respected for transparent investor communication. DSP Small Cap Fund and DSP Midcap Fund are flagship offerings.

Get the next move the moment it happens.

Follow DSP Mutual Fund and Concord Biotech Limited on WhaleWatch, alongside 300+ top investors, funds and FPIs. The newest moves are waiting for you inside.

Explore

Concord Biotech Limited shareholders DSP Mutual Fund's portfolio All investors All stocks

🤖 We track their every move, post, interview and article. Obsessively.

⚡ Every move reaches your feed in minutes, while it still carries an edge

📊 Stake changes, bulk deals and insider trades, all tracked in one place

📰 A two-minute morning brief, so you start the day already ahead

More moves in Concord Biotech Limited

Government Pension Fund Global (Norway)Decreased

Government Pension Fund Global (Norway) decreased its stake in Concord Biotech Limited from 2.99% to 2.95%, selling 36,910 shares.

19 Jul 2026

Max Life InsuranceDecreased

Max Life Insurance decreased its stake in Concord Biotech Limited from 1.52% to 1.34%, selling 187,698 shares. The value of the shares sold is ₹25.2 Cr at a share price of ₹1342.80.